The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Injectable Peptides Market 2024 by Company, Regions, Type and Application, Forecast to 2029

Global Injectable Peptides Market 2024 by Company, Regions, Type and Application, Forecast to 2029

Publishing Date : Jul, 2023

License Type :
 

Report Code : 1755980

No of Pages : 102

Ask Your Query

Synopsis
The global Injectable Peptides market size was valued at USD 33080 million in 2022 and is forecast to a readjusted size of USD 43880 million by 2029 with a CAGR of 4.1% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Injectable peptide drugs offer several advantages over other administration routes, such as oral or topical delivery. When injected, peptides can bypass the gastrointestinal tract, avoiding issues such as degradation by stomach acid or poor absorption. Additionally, injections can provide a more rapid and direct delivery of the drug into the bloodstream, allowing for faster onset of action.

Peptide-based injectable drugs refer to medications that contain peptides as their active ingredients and are administered via injection. Peptides are short chains of amino acids, which are the building blocks of proteins. They play crucial roles in various biological processes and can be used therapeutically to target specific cellular pathways or receptors.

This report is a detailed and comprehensive analysis for global Injectable Peptides market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

  • Global Injectable Peptides market size and forecasts, in consumption value ($ Million), 2018-2029
  • Global Injectable Peptides market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
  • Global Injectable Peptides market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
  • Global Injectable Peptides market shares of main players, in revenue ($ Million), 2018-2023

The Primary Objectives in This Report Are:

  • To determine the size of the total market opportunity of global and key countries
  • To assess the growth potential for Injectable Peptides
  • To forecast future growth in each product and end-use market
  • To assess competitive factors affecting the marketplace

This report profiles key players in the global Injectable Peptides market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, Teva, Novo Nordisk, Takeda and Eli Lilly, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation

Injectable Peptides market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

  • Brand
  • Generic Drug

Market segment by Application

  • Cancer
  • Metabolic Disorders
  • Central Nervous System
  • Other

Market segment by players, this report covers

  • Sanofi
  • Teva
  • Novo Nordisk
  • Takeda
  • Eli Lilly
  • AstraZeneca
  • Novartis
  • AbbVie
  • Ipsen
  • Ferring
  • Merck
  • The Medicines
  • Roche
  • J & J

Market segment by regions, regional analysis covers

  • North America (United States, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
  • South America (Brazil, Argentina and Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Injectable Peptides product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Injectable Peptides, with revenue, gross margin and global market share of Injectable Peptides from 2018 to 2023.
Chapter 3, the Injectable Peptides competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Injectable Peptides market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Injectable Peptides.
Chapter 13, to describe Injectable Peptides research findings and conclusion.

Index

1 Market Overview
1.1 Product Overview and Scope of Injectable Peptides
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Injectable Peptides by Type
1.3.1 Overview: Global Injectable Peptides Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Injectable Peptides Consumption Value Market Share by Type in 2022
1.3.3 Brand
1.3.4 Generic Drug
1.4 Global Injectable Peptides Market by Application
1.4.1 Overview: Global Injectable Peptides Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Cancer
1.4.3 Metabolic Disorders
1.4.4 Central Nervous System
1.4.5 Other
1.5 Global Injectable Peptides Market Size & Forecast
1.6 Global Injectable Peptides Market Size and Forecast by Region
1.6.1 Global Injectable Peptides Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Injectable Peptides Market Size by Region, (2018-2029)
1.6.3 North America Injectable Peptides Market Size and Prospect (2018-2029)
1.6.4 Europe Injectable Peptides Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Injectable Peptides Market Size and Prospect (2018-2029)
1.6.6 South America Injectable Peptides Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Injectable Peptides Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Injectable Peptides Product and Solutions
2.1.4 Sanofi Injectable Peptides Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Sanofi Recent Developments and Future Plans
2.2 Teva
2.2.1 Teva Details
2.2.2 Teva Major Business
2.2.3 Teva Injectable Peptides Product and Solutions
2.2.4 Teva Injectable Peptides Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Teva Recent Developments and Future Plans
2.3 Novo Nordisk
2.3.1 Novo Nordisk Details
2.3.2 Novo Nordisk Major Business
2.3.3 Novo Nordisk Injectable Peptides Product and Solutions
2.3.4 Novo Nordisk Injectable Peptides Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Novo Nordisk Recent Developments and Future Plans
2.4 Takeda
2.4.1 Takeda Details
2.4.2 Takeda Major Business
2.4.3 Takeda Injectable Peptides Product and Solutions
2.4.4 Takeda Injectable Peptides Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Takeda Recent Developments and Future Plans
2.5 Eli Lilly
2.5.1 Eli Lilly Details
2.5.2 Eli Lilly Major Business
2.5.3 Eli Lilly Injectable Peptides Product and Solutions
2.5.4 Eli Lilly Injectable Peptides Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Eli Lilly Recent Developments and Future Plans
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business
2.6.3 AstraZeneca Injectable Peptides Product and Solutions
2.6.4 AstraZeneca Injectable Peptides Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 AstraZeneca Recent Developments and Future Plans
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business
2.7.3 Novartis Injectable Peptides Product and Solutions
2.7.4 Novartis Injectable Peptides Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Novartis Recent Developments and Future Plans
2.8 AbbVie
2.8.1 AbbVie Details
2.8.2 AbbVie Major Business
2.8.3 AbbVie Injectable Peptides Product and Solutions
2.8.4 AbbVie Injectable Peptides Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 AbbVie Recent Developments and Future Plans
2.9 Ipsen
2.9.1 Ipsen Details
2.9.2 Ipsen Major Business
2.9.3 Ipsen Injectable Peptides Product and Solutions
2.9.4 Ipsen Injectable Peptides Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Ipsen Recent Developments and Future Plans
2.10 Ferring
2.10.1 Ferring Details
2.10.2 Ferring Major Business
2.10.3 Ferring Injectable Peptides Product and Solutions
2.10.4 Ferring Injectable Peptides Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Ferring Recent Developments and Future Plans
2.11 Merck
2.11.1 Merck Details
2.11.2 Merck Major Business
2.11.3 Merck Injectable Peptides Product and Solutions
2.11.4 Merck Injectable Peptides Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Merck Recent Developments and Future Plans
2.12 The Medicines
2.12.1 The Medicines Details
2.12.2 The Medicines Major Business
2.12.3 The Medicines Injectable Peptides Product and Solutions
2.12.4 The Medicines Injectable Peptides Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 The Medicines Recent Developments and Future Plans
2.13 Roche
2.13.1 Roche Details
2.13.2 Roche Major Business
2.13.3 Roche Injectable Peptides Product and Solutions
2.13.4 Roche Injectable Peptides Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Roche Recent Developments and Future Plans
2.14 J & J
2.14.1 J & J Details
2.14.2 J & J Major Business
2.14.3 J & J Injectable Peptides Product and Solutions
2.14.4 J & J Injectable Peptides Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 J & J Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Injectable Peptides Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Injectable Peptides by Company Revenue
3.2.2 Top 3 Injectable Peptides Players Market Share in 2022
3.2.3 Top 6 Injectable Peptides Players Market Share in 2022
3.3 Injectable Peptides Market: Overall Company Footprint Analysis
3.3.1 Injectable Peptides Market: Region Footprint
3.3.2 Injectable Peptides Market: Company Product Type Footprint
3.3.3 Injectable Peptides Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Injectable Peptides Consumption Value and Market Share by Type (2018-2023)
4.2 Global Injectable Peptides Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Injectable Peptides Consumption Value Market Share by Application (2018-2023)
5.2 Global Injectable Peptides Market Forecast by Application (2024-2029)
6 North America
6.1 North America Injectable Peptides Consumption Value by Type (2018-2029)
6.2 North America Injectable Peptides Consumption Value by Application (2018-2029)
6.3 North America Injectable Peptides Market Size by Country
6.3.1 North America Injectable Peptides Consumption Value by Country (2018-2029)
6.3.2 United States Injectable Peptides Market Size and Forecast (2018-2029)
6.3.3 Canada Injectable Peptides Market Size and Forecast (2018-2029)
6.3.4 Mexico Injectable Peptides Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Injectable Peptides Consumption Value by Type (2018-2029)
7.2 Europe Injectable Peptides Consumption Value by Application (2018-2029)
7.3 Europe Injectable Peptides Market Size by Country
7.3.1 Europe Injectable Peptides Consumption Value by Country (2018-2029)
7.3.2 Germany Injectable Peptides Market Size and Forecast (2018-2029)
7.3.3 France Injectable Peptides Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Injectable Peptides Market Size and Forecast (2018-2029)
7.3.5 Russia Injectable Peptides Market Size and Forecast (2018-2029)
7.3.6 Italy Injectable Peptides Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Injectable Peptides Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Injectable Peptides Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Injectable Peptides Market Size by Region
8.3.1 Asia-Pacific Injectable Peptides Consumption Value by Region (2018-2029)
8.3.2 China Injectable Peptides Market Size and Forecast (2018-2029)
8.3.3 Japan Injectable Peptides Market Size and Forecast (2018-2029)
8.3.4 South Korea Injectable Peptides Market Size and Forecast (2018-2029)
8.3.5 India Injectable Peptides Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Injectable Peptides Market Size and Forecast (2018-2029)
8.3.7 Australia Injectable Peptides Market Size and Forecast (2018-2029)
9 South America
9.1 South America Injectable Peptides Consumption Value by Type (2018-2029)
9.2 South America Injectable Peptides Consumption Value by Application (2018-2029)
9.3 South America Injectable Peptides Market Size by Country
9.3.1 South America Injectable Peptides Consumption Value by Country (2018-2029)
9.3.2 Brazil Injectable Peptides Market Size and Forecast (2018-2029)
9.3.3 Argentina Injectable Peptides Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Injectable Peptides Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Injectable Peptides Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Injectable Peptides Market Size by Country
10.3.1 Middle East & Africa Injectable Peptides Consumption Value by Country (2018-2029)
10.3.2 Turkey Injectable Peptides Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Injectable Peptides Market Size and Forecast (2018-2029)
10.3.4 UAE Injectable Peptides Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Injectable Peptides Market Drivers
11.2 Injectable Peptides Market Restraints
11.3 Injectable Peptides Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Injectable Peptides Industry Chain
12.2 Injectable Peptides Upstream Analysis
12.3 Injectable Peptides Midstream Analysis
12.4 Injectable Peptides Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Published By : GlobalInfoResearch

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock